35812346|t|Assessment of the safety of the cationic arginine-rich peptides (CARPs) poly-arginine-18 (R18 and R18D) in ex vivo models of mast cell degranulation and red blood cell hemolysis.
35812346|a|Our laboratory focuses on the development of novel neuroprotective cationic peptides, such poly-arginine-18 (R18: 18-mer of l-arginine; net charge +18) and its d-enantiomer R18D in stroke and other brain injuries. In the clinical development of R18/R18D, their cationic property raises potential safety concerns on their non-specific effects to induce mast cell degranulation and hemolysis. To address this, we first utilised primary human cultured mast cells (HCMCs) to examine anaphylactoid effects. We also included as controls, the well-characterised neuroprotective TAT-NR2B9c peptide and the widely used heparin reversal peptide, protamine. Degranulation assay based on beta-hexosaminidase release demonstrated that R18 and R18D did not induce significant mast cell degranulation in both untreated (naive) and IgE-sensitised HCMCs in a dose-response study to a maximum peptide concentration of 16 muM. Similarly, TAT-NR2B9c and protamine did not induce significant mast cell degranulation. To examine hemolytic effects, red blood cells (RBCs), were incubated with the peptides at a concentration range of 1-16 muM in the absence or presence of 2% plasma. Measurement of hemoglobin absorbance revealed that only R18 induced a modest, but significant degree of hemolysis at the 16 muM concentration, and only in the absence of plasma. This study addressed the potential safety concern of the application of the cationic neuroprotective peptides, especially, R18D, on anaphylactoid responses and hemolysis. The findings indicate that R18, R18D, TAT-NR2B9c and protamine are unlikely to induce histamine mediated anaphylactoid reactions or RBC hemolysis when administered intravenously to patients.
35812346	41	63	arginine-rich peptides	Chemical	-
35812346	65	70	CARPs	Chemical	-
35812346	72	88	poly-arginine-18	Chemical	-
35812346	90	93	R18	ProteinMutation	tmVar:p|Allele|R|18;VariantGroup:0;CorrespondingGene:10724;CorrespondingSpecies:9606
35812346	98	102	R18D	ProteinMutation	tmVar:p|SUB|R|18|D;HGVS:p.R18D;VariantGroup:0;CorrespondingGene:10724;CorrespondingSpecies:9606
35812346	168	177	hemolysis	Disease	MESH:D006461
35812346	255	263	peptides	Chemical	MESH:D010455
35812346	270	286	poly-arginine-18	Chemical	-
35812346	303	313	l-arginine	Chemical	MESH:D001120
35812346	352	356	R18D	ProteinMutation	tmVar:p|SUB|R|18|D;HGVS:p.R18D;VariantGroup:0;CorrespondingGene:10724;CorrespondingSpecies:9606
35812346	360	366	stroke	Disease	MESH:D020521
35812346	377	391	brain injuries	Disease	MESH:D001930
35812346	424	427	R18	ProteinMutation	tmVar:p|Allele|R|18;VariantGroup:0;CorrespondingGene:10724;CorrespondingSpecies:9606
35812346	428	432	R18D	ProteinMutation	tmVar:p|SUB|R|18|D;HGVS:p.R18D;VariantGroup:0;CorrespondingGene:10724;CorrespondingSpecies:9606
35812346	559	568	hemolysis	Disease	MESH:D006461
35812346	613	618	human	Species	9606
35812346	750	753	TAT	Gene	6898
35812346	789	796	heparin	Chemical	MESH:D006493
35812346	855	874	beta-hexosaminidase	Gene	10724
35812346	901	904	R18	ProteinMutation	tmVar:p|Allele|R|18;VariantGroup:0;CorrespondingGene:10724;CorrespondingSpecies:9606
35812346	909	913	R18D	ProteinMutation	tmVar:p|SUB|R|18|D;HGVS:p.R18D;VariantGroup:0;CorrespondingGene:10724;CorrespondingSpecies:9606
35812346	995	998	IgE	Gene	3497
35812346	1098	1101	TAT	Gene	6898
35812346	1186	1195	hemolytic	Disease	MESH:D006461
35812346	1253	1261	peptides	Chemical	MESH:D010455
35812346	1396	1399	R18	ProteinMutation	tmVar:p|Allele|R|18;VariantGroup:0;CorrespondingGene:10724;CorrespondingSpecies:9606
35812346	1444	1453	hemolysis	Disease	MESH:D006461
35812346	1619	1627	peptides	Chemical	MESH:D010455
35812346	1641	1645	R18D	ProteinMutation	tmVar:p|SUB|R|18|D;HGVS:p.R18D;VariantGroup:0;CorrespondingGene:10724;CorrespondingSpecies:9606
35812346	1678	1687	hemolysis	Disease	MESH:D006461
35812346	1716	1719	R18	ProteinMutation	tmVar:p|Allele|R|18;VariantGroup:0;CorrespondingGene:10724;CorrespondingSpecies:9606
35812346	1721	1725	R18D	ProteinMutation	tmVar:p|SUB|R|18|D;HGVS:p.R18D;VariantGroup:0;CorrespondingGene:10724;CorrespondingSpecies:9606
35812346	1727	1730	TAT	Gene	6898
35812346	1775	1784	histamine	Chemical	MESH:D006632
35812346	1825	1834	hemolysis	Disease	MESH:D006461
35812346	1870	1878	patients	Species	9606
35812346	Negative_Correlation	MESH:D001930	CorrespondingGene:10724;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p
35812346	Positive_Correlation	MESH:D006461	CorrespondingGene:10724;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p
35812346	Association	MESH:D006461	HGVS:p.R18D;CorrespondingGene:10724
35812346	Negative_Correlation	MESH:D010455	MESH:D001930
35812346	Association	MESH:D001930	HGVS:p.R18D;CorrespondingGene:10724
35812346	Association	MESH:D020521	CorrespondingGene:10724;CorrespondingSpecies:9606;VariantGroup:0;tmVar:p
35812346	Negative_Correlation	MESH:D010455	MESH:D020521
35812346	Negative_Correlation	MESH:D020521	HGVS:p.R18D;CorrespondingGene:10724
35812346	Positive_Correlation	MESH:D010455	MESH:D006461
35812346	Association	MESH:D001930	10724
35812346	Association	MESH:D006461	10724
35812346	Association	MESH:D020521	10724

